ALL ORDINARIES finishes lower Wednesday: 8 shares you missed

The S&P/ASX 200 (Index:^AXJO)(ASX:XJO) and ALL ORDINARIES (Index:^AXAO) (ASX:XAO) finished lower on Wednesday.

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Australia's S&P/ASX 200 (Index: ^AXJO)(ASX: XJO) and ALL ORDINARIES (Index: ^AXAO) (ASX: XAO) indices finished lower on Wednesday.

Here's a short recap of the Australian market:

  • S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) lower 0.22% to 6,161.20
  • ALL ORDINARIES (Index: ^AXAO) (ASX: XAO) lower 0.23% to 6,246.00
  • AUD/USD at US 71 cents
  • Gold at US$1,304.71 an ounce
  • Brent Oil at US$66.89 a barrel

The best-performing ASX 200 share today was gold miner Saracen Mineral Holdings Limited (ASX: SAR), its share price rose by 5.8%.

In-fact, several gold miners performed well today with the gold price increasing. The Newcrest Mining Limited (ASX: NCM) share price went up 3.1%.

Shares of Sigma Healthcare Ltd (ASX: SIG) dropped 12.3% today as its Board rejected the takeover offer from Australian Pharmaceutical Industries Ltd (ASX: API), which dropped 3.6%.

The share price of property business GPT Group (ASX: GPT) dropped 0.6% as it announced it has reached a binding agreement to sell its stake of the MLC Centre for $800 million.

Appen Ltd (ASX: APX) shares have rebounded 5.1% higher today with the machine learning business recovering some of the lost ground from when it returned to trade from its trading halt.

The Magellan Global Trust (ASX: MGG) share price dropped 2.1% today as its newly issued units hit the ASX boards.

Finally, New Hope Corporation Limited (ASX: NHC) shares are 4.3% higher with the New Acland Stage 3 Environment Authority amendment being granted.

Here are some of today's top stories:

Motley Fool contributor Tristan Harrison owns shares of MAGLOBTRST UNITS. The Motley Fool Australia owns shares of Appen Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Stock market chart in green with a rising arrow symbolising a rising share price.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a massive day for the ASX 200, with a new all-time high recorded.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Technology Shares

This ASX tech stock rocketed 60% in March! Can it keep on delivering?

After soaring in March, the ASX tech stock is now up 169% since this time last year.

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Mesoblast, Newmont, Pilbara Minerals, and Platinum shares are jumping

These ASX shares are ending the week strongly. But why?

Read more »

A young male ASX investor raises his clenched fists in excitement because of rising ASX share prices today
Share Gainers

3 ASX All Ords shares up 50%+ in March

These ASX shares have been on fire this month. But why?

Read more »

Woman looks amazed and shocked as she looks at her laptop.
Share Gainers

Why Mesoblast, Patriot Battery Metals, Sigma, and Zip shares are pushing higher

These shares are having a good session on hump day. But why?

Read more »

Woman looks amazed and shocked as she looks at her laptop.
Consumer Staples & Discretionary Shares

If you'd put $20,000 in this ASX retail stock at the start of 2023, you'd have $134,000 now

This online retailer has executed a remarkable turnaround for its investors.

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

It was back to earth for ASX shares this Tuesday.

Read more »

Two happy scientists analysing test results.
Healthcare Shares

Mesoblast share price rockets 36% on breaking FDA news

ASX investors are sending the Mesoblast share price soaring following promising FDA news.

Read more »